RSV vaccine clinical trials reported higher frequencies of atrial fibrillation in intervention groups compared to control. In this large, population-based, propensity-matched study, we found RSV vaccine was not associated with increased risk of new-onset or recurrent atrial fibrillation within 1-42 days compared to influenza or Tdap vaccines.

中文翻译：

---

老年人接种 RSV 疫苗后的心房颤动


RSV 疫苗临床试验报告称，与对照组相比，干预组的心房颤动发生率更高。在这项基于人群的大型倾向匹配研究中，我们发现与流感或 Tdap 疫苗相比，RSV 疫苗与 1-42 天内新发或复发性心房颤动的风险增加无关。